VRVera Ribeiro

Vera Ribeiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vera Ribeiro has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism

    by Jorge C. Correia, Julie Massart, Jan Freark de Boer, Margareta Porsmyr-Palmertz, Vicente Martínez-Redondo, Leandro Z. Agudelo, Indranil Sinha, David Meierhofer, Vera Ribeiro, Marie Björnholm, et al.


  • The effect of phosphate on the nuclease activity of vanadium compounds

    by Nataliya Butenko, José Paulo Pinheiro, José Paulo Da Silva, Ana Isabel Tomaz, Isabel Correia, Vera Ribeiro, João Costa Pessoa, Isabel Cavaco


  • Open Access

    Cucurbiturils as supramolecular inhibitors of DNA restriction by type II endonucleases

    by Cátia Parente Carvalho, Amir Norouzy, Vera Ribeiro, Werner M. Nau, Uwe Pischel

    Cucurbiturils inactivate the restriction reaction of type II endonucleases via supramolecular interactions. This was monitored for different enzyme–DNA combinations in the absence and presence of organic macrocycles. The process can be re-activated by competitive displacement on addition of polyamines.


  • Drug Metabolism and Transport Under Hypoxia

    by A.L. Ribeiro, V. Ribeiro

    Tumour progression is characterized by a rapid cell growth accompanied by changes in the microenvironment, largely due to hypoxia. The angiogenic switch involves changes in the expression of genes that play key roles in tumour progression, invasion, metastasis and therapeutic response, contributing to tumour aggressiveness. The effect of hypoxia on the cellular concentrations of drug metabolizing enzymes and transporters is much less understood. A brief summary of the signaling mechanisms triggered by hypoxia is presented, followed by a review of the known effects of hypoxia on drug metabolism and transport. Most of the studies available have focused on Cytochromes P450 and ATP-binding cassette transporters, while influx transporters of the SLC family have been less investigated. Given its potential to contribute both to the understanding of the pathogenesis of disease and to the optimization of therapeutics, it is rather surprising that this area of research is still underdeveloped. An increasing number of studies focusing on this subject are bound to provide key information for drug development and optimization of therapeutics.


    • 1 June 2013
      • Vol. 33  (6) , 2549-2555

    Lack of Relevance of HIF-1 alpha Polymorphisms in Breast Cancer in a Portuguese Population

    by Ana Luisa Ribeiro, Jorge F. Gaspar, Teresa Pereira, Vera Ribeiro

    We aimed to study the prevalence of Hypoxia inducible factor-1 alpha (HIF-1 alpha) P582S and A588T polymorphisms in a Portuguese breast cancer population and its effect on the transcriptional activity of HIF-1 alpha in MCF7 breast adenocarcinoma cells. We performed a polymerase chain Reaction - restriction fragment length polymorphism (PCR-RFLP)-based genotyping of a Portuguese breast cancer population for two HIF-1 alpha polymorphisms. Furthermore, by site-directed muta genesis, we generated a variant form of HIF-1 alpha and compared its transcriptional activity with the wild-type HIF-1 alpha in MCF7 cells. There were no significant differences in genotypic frequencies for P582S and A588T between breast cancer patients and controls, nor between the transcriptional activity of the 582S mutant and the wild-type HIF-1 alpha. In conclusion, there is no association between HIF-1 alpha polymorphisms and incidence of breast cancer in the Portuguese examined population. Furthermore, the P582S mutation does not affect transcriptional activity of HIF-1 alpha in breast cancer cells, contrary to previous findings in other cell lines, suggesting that the impact of this mutation is cell-type specific.


  • Open Access

    Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism

    by Vera Dias, V Ribeiro

    It is well known that drug disposition and response are greatly determined by the activities of drug metabolizing enzymes, which are polymorphic. Some of these polymorphisms are clinically relevant and presented an ethnic-dependent pattern of distribution. The characterization of the genetic distribution of different populations allows the selection of therapeutic options in accordance with the genetic background, with the objective to avoid adverse reactions and inefficacy of the treatment. In this work, we studied selected genetic polymorphisms in drug metabolizing enzymes in three different ethnic groups - Portugal, Mozambique and Colombia. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping methods were developed for drug metabolizing enzymes, namely, cholesterol 7α-hydroxylase (CYP7A1) (−203A>C, −346C>T, −496C>T, N233S, G347S), sterol 27-hydroxylase (CYP27A1) (R164W, A169V, D273N, V400A) and oxysterol 7α-hydroxylase (CYP7B1) (−116C>G, R324H, 1774C>T) to characterize the allelic distribution of these polymorphisms among three different ethnic/geographic origins. A total of 12 CYP7A1, CYP27A1 and CYP7B1 genetic variants were genotyped in a sample of 92 Portuguese, 151 Mozambican and 91 Colombian subjects. The variants N233S in CYP7A1 and 1774C>T in CYP7B1 were not detected in any population studied. The promoter polymorphisms in CYP7A1 (−203A>C, −346C>T, −496C>T) had high frequency in the three ethnic groups. G347S (CYP7A1), R164W, A169V and V400A (CYP27A1) were present in a low frequency but with a similar distribution in the three ethnic groups. Significant differences were observed for D273N (CYP27A1), −346C>T (CYP7A1), −116C>G and R324H (CYP7B1)Our results demonstrate a high variability of drug metabolizing enzymes between the different populations analyzed, indicating that at least some of these polymorphisms are ethnic specific.


  • Open Access

    Plasmodium infection alters Anopheles gambiae detoxification gene expression

    by Rute C Félix, Pie Müller, Vera Ribeiro, Hilary Ranson, Henrique Silveira

    Background: Anopheles gambiae has been shown to change its global gene expression patterns upon Plasmodium infection. While many alterations are directly related to the mosquito's innate immune response, parasite invasion is also expected to generate toxic by-products such as free radicals. The current study aimed at identifying which loci coding for detoxification enzymes are differentially expressed as a function of Plasmodium berghei infection in midgut and fat body tissues. Results: Using a custom-made DNA microarray, transcript levels of 254 loci primarily belonging to three major detoxification enzyme families (glutathione S-transferases, cytochrome P450 monooxygenases and esterases) were compared in infected and uninfected mosquitoes both during ookinete invasion and the release of sporozoites into the hemocoel. The greatest changes in gene expression were observed in the midgut in response to ookinete invasion. Interestingly, many detoxification genes including a large number of P450s were down-regulated at this stage. In the fat body, while less dramatic, gene expression alterations were also observed and occurred during the ookinete invasion and during the release of sporozoites into the hemocoel. While most gene expression changes were tissue-related, CYP6M2, a CYP previously associated with insecticide resistance, was over-expressed both in the midgut and fat body during ookinete invasion. Conclusions: Most toxicity-related reactions occur in the midgut shortly after the ingestion of an infected blood meal. Strong up-regulation of CYP6M2 in the midgut and the fat body as well as its previous association with insecticide resistance shows its broad role in metabolic detoxification.


  • Ethnic variability of HIF-1α polymorphisms

    by A.L. Ribeiro, J. Correia, V. Ribeiro

    The hypoxia-inducible factor -1α (HIF-1α) is a transcription factor that plays a crucial role in the cellular response to hypoxia. The C1772T (P582S) and G1790A (A588T) polymorphisms, within the oxygen dependent degradation domain of HIF-1α protein,


  • DNA cleavage activity of VIVO(acac)2 and derivatives

    by Nataliya Butenko, Ana Isabel Tomaz, Ofelia Nouri, Esther Escribano, Virtudes Moreno, Sofia Gama, Vera Ribeiro, João Paulo Telo, João Costa Pesssoa, Isabel Cavaco